Fosaprepitant Use as an Antiemetic to Prevent Postoperative Nausea and Vomiting in Pediatric Spinal Fusion Patients May Be Associated With More Rapid Transition to Oral Pain Medication and Reduced Length of Stay

Fosaprepitant Use as an Antiemetic to Prevent Postoperative Nausea and Vomiting in Pediatric Spinal Fusion Patients May Be Associated With More Rapid Transition to Oral Pain Medication and Reduced Length of Stay

Background: Significant postoperative nausea and vomiting (PONV) in pediatric patients undergoing posterior spinal fusion is common and limits recovery, prolonging hospital stay. Fosaprepitant is a long-acting antiemetic and works by blocking substance P binding to the neurokinin-1 (NK1) receptor. T...

Full description

Saved in:
Bibliographic Details
Main Authors: Jennifer Busse, Aaron Louie, Jennifer Crotty, Albert Lin, Zarema Muratova, Matan Malka, Ritt Givens, Benjamin Roye, Michael Vitale, William Schechter
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Journal of the Pediatric Orthopaedic Society of North America
Subjects:
Pediatrics
Spinal fusion
Postoperative nausea and vomiting
Length of stay
Online Access:http://www.sciencedirect.com/science/article/pii/S2768276525000185
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items